Medigap Agents More Likely to Sell Life and Indexed Annuities: Agent Link

News April 23, 2019 at 02:49 PM
Share & Print

Medicare card (Image: CMS) (Image: Centers for Medicare and Medicaid Services)

Agents who focus on selling Medicare supplement (Medigap) insurance policies seem to be a lot more likely to cross-sell many other life, health and annuity products.

Stu Gramajo, market research director at Agent Link, has published data supporting that conclusion in a new summary of results from a survey of 1,200 licensed insurance agents.

The Clearwater, Florida-based insurance marketing firm provided ThinkAdvisor with special access to the summary. The summary is not currently available to members of the public.

Gramajo found that 29% of the agents surveyed are active in the market for products aimed at older consumers. About one-third of those agents sell Medigap policies,  and about one-fifth sell Medicare Advantage coverage.

Both types of agents were equally to sell indexed universal life (IUL) policies: 27% of Medigap specialists and 27% of Medicare Advantage specialists sell IUL.

Medicare Advantage agents were more likely to sell property & casualty coverage; About 27% of them said they sell P&C coverage. Only 12% of Medigap agents said they sell P&C coverage.

But the Medigap agents were much more likely to report selling products such as permanent life insurance, term life, short-term medical insurance, long-term care insurance and variable annuities.

About 65% of Medigap agents sell permanent life and term life, for example, and 8% sell variable annuities.

Only 47% of Medicare Advantage specialists said they sell term life, and just 40% offer permanent life. The percentage of Medicare Advantage specialists who said they sell variable annuities was at or close to zero.

— Connect with ThinkAdvisor Life/Health on LinkedIn and Twitter.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Related Stories

Resource Center